PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Summary

This study is sponsored by Sierra Oncology, Inc. formerly ProNAi Therapeutics, Inc. It is a multi-center, single-arm, 2-stage, open-label phase II investigation of PNT2258 to characterize anti-tumor activity and collect safety data on patients with Richter's Transformation.

Timeline

Start

2015-08

Primary completion

2016-06

Completion

2016-06

Drugs

Indications